FDA OKs Phase 2 Study of Antria’s Stem Cell Technology in Plastic Surgery
Antria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
Antria Inc announced that the FDA has approved a Phase 2 study of autologous adipose derived stem cells in plastic surgery. The future is now. #regenerativemedicine
BTL’s Emsculpt Neo has received FDA clearance to stimulate neuromuscular tissue in the legs and arms for rehabilitation, expanding its original use for fat reduction and muscle building to now address medical conditions and improve patients’ mobility and recovery.